PPARGC1A and metabolic dysfunction-associated steatotic liver disease: Although the effects of PPARGC1A SNPs are only reported in these three populations, the polymorphisms of PPARGC1A have been linked to many other metabolic diseases [155], thus highlighting its possible contribution to NAFLD disease.